About ezDiaTECH
ezDiaTECH is a company based in Cheonan (South Korea) founded in 2016. ezDiaTECH offers products and services including VEUS and VEUPLEX™ TBI assay. ezDiaTECH operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
- Headquarter Cheonan, South Korea
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ezdiatech.com
- Social LinkedIn
- Legal Name 주식회사 이지다이아텍
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of ezDiaTECH
ezDiaTECH operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of ezDiaTECH
ezDiaTECH offers a comprehensive portfolio of products and services, including VEUS and VEUPLEX™ TBI assay.
Automated platform for rapid and accurate disease detection using AI.
Kit for quick traumatic brain injury diagnosis via biomarkers.
Competitors of ezDiaTECH
ezDiaTECH operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| me-med.com | 2009 | Tirat Carmel, Israel | $163M | – | Provider of machine learning based diagnostic solutions for infectious diseases | |
| visbymedical.com | 2010 | San Jose, United States | $386.33M | 251 | Portable PCR diagnostics for infectious diseases are developed. | |
| genmarkdx.com | 1993 | San Diego, United States | $8.56M | 797 | Instruments and test panels for multiplexed molecular diagnostics are provided. | |
| sunbirdbio.com | 2020 | Singapore | $14M | – | Diagnostic technologies for infectious, cancer, and neurological diseases are developed. | |
| t2biosystems.com | 2006 | Lexington, United States | $454.3M | 166 | Miniaturized MRI platforms for clinical diagnostics are developed. | |
| biomeme.com | 2013 | Philadelphia, United States | $6.2M | 202 | Smartphone-based DNA detection platform is developed for diagnostics. | |
| biofiredx.com | 1990 | Salt Lake, United States | $84M | 8 | Molecular diagnostic solutions for genetic condition detection are provided. | |
| molbiodiagnostics.com | 2000 | Salcete, India | $123.98M | 714 | Point-of-care molecular platforms for infectious disease detection are developed. |
Detailed competitors of ezDiaTECH
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ezDiaTECH
The website of ezDiaTECH (ezdiatech.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 9.7% vs previous month
Similar companies to ezDiaTECH
10 companies that operate in the same segment as ezDiaTECH (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | – | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ezDiaTECH
ezDiaTECH was founded in 2016.
ezDiaTECH is headquartered in Cheonan, South Korea. It is registered at Cheonan, Chungcheongnam-do, South Korea.
ezDiaTECH was founded in 2016 and is based in Cheonan, South Korea. In-vitro diagnostic assays targeting multiple diseases are developed and supplied by the company within the healthcare sector. Operations focus on medical diagnostics, with services extending to assay production and distribution for clinical applications. The firms activities are centered in the biotechnology field, supporting disease detection through reliable testing solutions across various regions.
ezDiaTECH's top competitors include Visby Medical, Inflammatix and MeMed.
ezDiaTECH offers VEUS and VEUPLEX™ TBI assay.
ezDiaTECH operates through ,.